Stocklytics Platform
Asset logo for symbol OMCL
Omnicell
OMCL47
$30.69arrow_drop_up2.47%$0.73
Asset logo for symbol OMCL
OMCL47

$30.69

arrow_drop_up2.47%
Key Stats
Open$30.78
Prev. Close$29.92
EPS0.27
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range29.92
31.68
52 Week Range25.12
55.49
Ratios
EPS0.27
Fundamentals
Payout Ratio-
Industry average yield2.87%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

OMCL-
US Healthcare Sector-
US Market-
check_circle

OMCL / Market

OMCL exceeded the US Market which returned 1.35% over the last twenty four hours.
warning

OMCL / Healthcare Sector

OMCL lose to the US Healthcare sector which returned 3.60% over the last twenty four hours.

Omnicell (OMCL) Statistics

Omnicell Inc. (OMCL) is a healthcare technology company that provides automation and business analytics software solutions for medication and supply management in healthcare settings. The company's products and services enable healthcare organizations to streamline their workflows, improve patient safety, and optimize inventory management. Omnicell's solutions are used in various healthcare settings, including hospitals, long-term care facilities, and pharmacies.
When it comes to valuation metrics, Omnicell Inc. (OMCL) has a Price/Book ratio of 8.16. This ratio is used to compare a company's market value to its book value, and a higher ratio indicates that the market values the company's assets more than its liabilities. Omnicell's Price/Sales ratio is 5.28, which is relatively higher compared to the industry average of 2.97. This ratio measures the company's market value relative to its annual revenue. Overall, these valuation metrics suggest that Omnicell Inc. (OMCL) might be overvalued in the market.
add Omnicell  to watchlist

Keep an eye on Omnicell

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Omnicell (OMCL) stock's performance compared to its sector and the market over the past year?

Over the past year, Omnicell (OMCL) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 22.20%, Omnicell has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 37.38%, it has fallen short of the market average. This comparison highlights Omnicell 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Omnicell (OMCL) stock?

The PE (Price to Earnings) ratio of Omnicell (OMCL) is currently 113.67. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Omnicell (OMCL) stock?

The Earnings Per Share (EPS) for Omnicell (OMCL), calculated on a diluted basis, is $0.27. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Omnicell (OMCL) stock?

The operating margin for Omnicell (OMCL) is 4.43%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Omnicell (OMCL) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Omnicell (OMCL) is $90.09M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Omnicell (OMCL) have?

Omnicell (OMCL) has a total debt of $382.55M. The net debt, which accounts for cash and cash equivalents against the total debt, is $2.64M.

Take Your Investments to a Whole New Level